1. Fenretinide treatment accelerates atherosclerosis development in apoE‐deficient mice in spite of beneficial metabolic effects. (14th November 2019) Authors: Busnelli, Marco; Manzini, Stefano; Bonacina, Fabrizia; Soldati, Sabina; Barbieri, Silvia Stella; Amadio, Patrizia; Sandrini, Leonardo; Arnaboldi, Francesca; Donetti, Elena; Laaksonen, Reijo; Paltrinieri, Saverio; Scanziani, Eugenio; Chiesa, Giulia Journal: British journal of pharmacology Issue: Volume 177:Number 2(2020) Page Start: 328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗